Please provide your email address to receive an email when new articles are posted on . Weekly injectable is first new treatment for candidemia and invasive candidiasis in more than a decade. Rezzayo ...

Home remedies for yeast infections may include garlic, yogurt, probiotics, boric acid, baking soda, and more, but it's ...

The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program.2,3 If ...

Credit: Melinta Therapeutics. Rezzayo is supplied as a solid (cake or powder) in a single-dose vial containing 200mg of rezafungin. Rezzayo ™ (rezafungin for injection) is now available for the ...

In a recent Science Advances study, scientists have developed a novel nanozyme-probiotic combination therapy for Candida vaginitis, which shows potency in killing the causative pathogen, restoring ...

A new study has uncovered how a surprising player in the immune system, eosinophils, best known for their role in allergies ...

A case report of a patient with acute leukemia who developed chronic disseminated candidiasis revealed difficulties in diagnosing and treating the illness. Proper care and an accurate diagnosis were ...

New research shows that eosinophils, immune cells usually linked to allergies, also play a protective role against Candida ...

Halberd Demonstrates Eradication of Candida Auris Fungus in as little as 5 minutes. JACKSON CENTER, PA / ACCESSWIRE / February 13, 2023 / Halberd Corporation (OTC PINK:HALB) a leading provider of ...

Loramyc has the potential to become the first treatment in tablet form for oropharyngeal candidiasis in Japan, according to Shinichi Tamura, CEO of Sosei Group. Oropharyngeal candidiasis is commonly ...

Clinical cases of Candida auris, an emerging fungus considered an urgent threat, nearly doubled in 2021, according to new data from the US Centers for Disease Control and Prevention. There was also a ...

The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program.2,3 If ...